Objective The present study investigated the effects of switching to different products of the
same off-patent active substance (brand name or generic) on therapy discontinuation or …

Abstract Since August 2012, Italian general practitioners are required to prescribe the
generic name of medicines, except for refill of chronic therapy. We evaluated the extent of …

Background The use of generics, equivalent but less expensive drugs, is an important
opportunity to reduce healthcare expenditure. Methods The purpose of this study was to …

Objectives This paper analyses generic-to-branded drug switch-back patterns in the statin
class. Methods Utilizing LifeLink™ Anonymized Patient Level Data (APLD) from IMS Health …

Background: Healthcare systems throughout the world are under increasing pressure to
control and minimise costs. The substitution of initially-prescribed drugs with cheaper …

Purpose Many studies of persistence involving fixed dose combinations (FDCs) of
cardiovascular medicines have not adequately accounted for a user's prior experience with …

Background Although generic drugs have been approved with the assurance of
interchangeable applications with original drugs, some physicians, and patients still view …

Objective: To study the extent of brand substitution and switching in three commonly used
classes of drugs available on the Pharmaceutical Benefits Scheme (PBS). Design, setting …

Aims: This short report was designed to provide 2‐year follow‐up data from a previous study
carried out in a primary care practice in the UK to assess the clinical and practical …

Abstract Background/Introduction Large randomized clinical trials have shown the efficacy of
aspirin (ASA), angiotensin converting enzyme inhibitors (ACEI) and statins (S) in secondary …